This pattern is consistent with emerging evidence that metabolic dysfunction and impaired insulin signaling contribute to AD pathogenesis through mechanisms involving neurovascular injury, chronic inflammation, and amyloid accumulation42–44. The gene discussed is INS; the disease is Alzheimer disease.